The stock of CRISPR Therapeutics AG (CRSP) has gone up by 13.91% for the week, with a 16.46% rise in the past month and a
Additionally, the 36-month beta value for CRSP is 1.74. There are mixed opinions on the stock, with 12 analysts rating it as a “buy,” 5
The 36-month beta value for CRSP is also noteworthy at 1.76. There are mixed opinions on the stock, with 12 analysts rating it as a
The 36-month beta value for CRSP is also noteworthy at 1.76. There are mixed opinions on the stock, with 12 analysts rating it as a
The stock of CRISPR Therapeutics AG (CRSP) has seen a 5.67% increase in the past week, with a -6.75% drop in the past month, and
The 36-month beta value for CRSP is also noteworthy at 1.81. There are mixed opinions on the stock, with 12 analysts rating it as a
© 2024, Powered by Smart TechOne